NorthShore University HealthSystem First in Illinois to Use Innovative Technology to Recognize Potential for Alzheimer’s Disease in Patients

Scan identifies a marker of cognitive decline by looking at brain plaque content, which previously could only be evaluated in deceasedEvanston, IL – June 28, 2012 – NorthShore University HealthSystem  (NorthShore) is the first health system in the state of Illinois to evaluate patients for Alzheimer’s Disease (AD) utilizing Amyvid (Florbetapir F 18 Injection) -- the first and only radioactive diagnostic agent approved for Positron Emission Tomography (PET) imaging of plaques in the living brain (approved by the FDA in April 2012). The drug is being used to